Osimertinib/selpercatinibVarious toxicities and acquired resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1906卷 / 1期

关键词：

D O I：

10.1007/s40278-022-15212-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：322 / 322

相关论文

共 50 条

[1] Lenvatinib/selpercatinibVarious toxicities: case report
[J]. Reactions Weekly, 2023, 1946 (1) : 317 - 317
[2] Cabozantinib/selpercatinibVarious toxicities: case report
[J]. Reactions Weekly, 2021, 1850 (1) : 85 - 85
[3] Erlotinib/osimertinib/rociletinibAcquired osimertinib resistance and various other toxicities: case report
[J]. Reactions Weekly, 2019, 1780 (1) : 155 - 155
[4] Osimertinib/trametinibVarious toxicities along with drug resistance: case report
[J]. Reactions Weekly, 2019, 1777 (1) : 189 - 189
[5] Acquired resistance to osimertinib in advanced lung cancer: A case report
Xu, Jiayi
Xu, Zikai
Hong, Jianwei
Zhou, Xiaoyu
[J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (08) : 3763 - 3764
[6] Carboplatin/osimertinib/pemetrexedNephrotoxicity and acquired drug resistance: case report
[J]. Reactions Weekly, 2021, 1879 (1) : 89 - 89
[7] Afatinib/osimertinibSkin toxicity and acquired resistance to osimertinib: case report
[J]. Reactions Weekly, 2017, 1666 (1) : 18 - 18
[8] SelpercatinibVarious toxicities: 5 case reports
[J]. Reactions Weekly, 2020, 1801 (1) : 231 - 231
[9] Multiple drugsVarious toxicities and acquired resistance: case report
[J]. Reactions Weekly, 2021, 1886 (1) : 300 - 300
[10] OsimertinibSquamous cell transformation following acquired resistance to osimertinib: case report
[J]. Reactions Weekly, 2019, 1778 (1) : 348 - 348

← 1 2 3 4 5 →